Gene expression and mitotic exit induced by microtubule-stabilizing drugs.

To explore the molecular mechanisms underlying the actions of Taxol and the functionally related molecule epothilone B (EpoB), we have analyzed the gene expression profiles in A549 cells in response to increasing concentrations of these microtubule-stabilizing drugs. An almost identical expression pattern was observed in cells treated with either Taxol or EpoB. Low concentrations of the drugs induced aberrant mitosis including asymmetric and multipolar cell divisions. At drug concentrations that triggered G(2)-M arrest, cells escaped from a prolonged mitotic arrest without cell division, resulting in tetraploid G(1) cells. This mitotic slippage is correlated with diminished expression of cdc2 kinase, topoisomerase IIalpha, BUB3, and BUB2-like protein 1, as well as with an increased expression of 14-3-3-sigma. Poly(ADP-ribose) polymerase cleavage, an early indicator of apoptosis, occurred in cells undergoing mitotic slippage and in aneuploid cells resulting from aberrant mitosis. In contrast, cells arrested in mitosis demonstrated no signal for apoptosis but had an increased expression of survivin, an inhibitor of apoptosis. Induction of aneuploid or tetraploid G(1) cells was accompanied by increased expression of CD95, p21, and BTG2 that may contribute to cell death because their expression was diminished in an EpoB-resistant cell line. In contrast, expression of GADD45 and PTGF-beta could promote cell survival. We conclude that abnormal mitotic exit is required for apoptotic cell death induced by microtubule-stabilizing drugs.

[1]  R. Jove,et al.  Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis. , 2003, Cancer research.

[2]  Mary Helen Barcellos-Hoff,et al.  Transforming growth factor-beta1 mediates cellular response to DNA damage in situ. , 2002, Cancer research.

[3]  M. Blagosklonny Sequential activation and inactivation of G2 checkpoints for selective killing of p53-deficient cells by microtubule-active drugs , 2002, Oncogene.

[4]  S. Elledge,et al.  Bub2 Is a Cell Cycle Regulated Phospho-Protein Controlled by Multiple Checkpoints , 2002, Cell cycle.

[5]  H. Broxmeyer,et al.  P21waf-1-Chk1 Pathway Monitors G1 Phase Microtubule Integrity and Is Crucial for Restriction Transition , 2002, Cell cycle.

[6]  T. Fojo,et al.  Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Altieri,et al.  A p34(cdc2) survival checkpoint in cancer. , 2002, Cancer cell.

[8]  V. Tron,et al.  GADD45 regulates G2/M arrest, DNA repair, and cell death in keratinocytes following ultraviolet exposure. , 2002, The Journal of investigative dermatology.

[9]  S. Mani,et al.  Validation of the pharmacodynamics of BMS-247550, an analogue of epothilone B, during a phase I clinical study. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  A. Valette,et al.  PP1 phosphatase is involved in Bcl-2 dephosphorylation after prolonged mitotic arrest induced by paclitaxel. , 2002, Biochemical and biophysical research communications.

[11]  S. Horwitz,et al.  Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs. , 2002, Cancer research.

[12]  S. de Jong,et al.  Fas receptor‐mediated apoptosis: a clinical application? , 2002, The Journal of pathology.

[13]  M. Lotze,et al.  TRAIL, Fasl and a blocking anti‐DR5 antibody augment paclitaxel‐induced apoptosis in human non‐small‐cell lung cancer , 2002, International journal of cancer.

[14]  T. Fojo,et al.  Paclitaxel-Induced FasL-Independent Apoptosis and Slow (Non-Apoptotic) Cell Death , 2002, Cancer biology & therapy.

[15]  J. Manfredi,et al.  Multiple roles of the tumor suppressor p53 , 2002, Current opinion in oncology.

[16]  M. Rajeevan,et al.  Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies. , 2001, Methods.

[17]  S. Kaufmann,et al.  A multistep model for paclitaxel-induced apoptosis in human breast cancer cell lines. , 2001, Experimental cell research.

[18]  U. Klar,et al.  Subcellular distribution of epothilones in human tumor cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  F. Zunino,et al.  Cell cycle checkpoint efficiency and cellular response to paclitaxel in prostate cancer cells , 2001, The Prostate.

[20]  T. Fojo,et al.  Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity , 2001, Oncogene.

[21]  K. Vousden,et al.  Regulation and function of the p53 tumor suppressor protein. , 2001, Current opinion in cell biology.

[22]  G. Getz,et al.  DNA microarrays identification of primary and secondary target genes regulated by p53 , 2001, Oncogene.

[23]  G. Stark,et al.  Regulation of the G2/M transition by p53 , 2001, Oncogene.

[24]  H. Saya,et al.  Mechanism of hyperploid cell formation induced by microtubule inhibiting drug in glioma cell lines , 2001, Oncogene.

[25]  J. Pietenpol,et al.  Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner , 2001, Oncogene.

[26]  B. Kennedy,et al.  NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. , 2000, Genes & development.

[27]  S. Arkin,et al.  Taxol and anti-stathmin therapy: a synergistic combination that targets the mitotic spindle. , 2000, Cancer research.

[28]  K. Vousden,et al.  Stress Signals Utilize Multiple Pathways To Stabilize p53 , 2000, Molecular and Cellular Biology.

[29]  D. Notterman,et al.  Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. , 2000, Genes & development.

[30]  Meek Dw The role of p53 in the response to mitotic spindle damage. , 2000 .

[31]  D. Guardavaccaro,et al.  Arrest of G1-S Progression by the p53-Inducible Gene PC3 Is Rb Dependent and Relies on the Inhibition of Cyclin D1 Transcription , 2000, Molecular and Cellular Biology.

[32]  K. Guan,et al.  PTGF-β, a type β transforming growth factor (TGF-β) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-β signaling pathway , 2000 .

[33]  D. Meek The role of p53 in the response to mitotic spindle damage. , 2000, Pathologie-biologie.

[34]  G. Peters,et al.  Drug-induced apoptosis in lung cnacer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[35]  G. Wahl,et al.  p53 regulation by post-translational modification and nuclear retention in response to diverse stresses , 1999, Oncogene.

[36]  K. Kinzler,et al.  Identification and classification of p53-regulated genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Z. Zong,et al.  Lack of synchrony among multiple nuclei induces partial DNA fragmentation in V79 cells polyploidized by demecolcine , 1999, Cell proliferation.

[38]  G. Stark,et al.  Mechanisms of G2 arrest in response to overexpression of p53. , 1999, Molecular biology of the cell.

[39]  T. Fojo,et al.  Molecular effects of paclitaxel: Myths and reality (a critical review) , 1999, International journal of cancer.

[40]  P Ubezio,et al.  Measuring the complexity of cell cycle arrest and killing of drugs: kinetics of phase-specific effects induced by taxol. , 1999, Cytometry.

[41]  T. K. Yeung,et al.  The mode of action of taxol: apoptosis at low concentration and necrosis at high concentration. , 1999, Biochemical and biophysical research communications.

[42]  M. Kirsch‐Volders,et al.  p53-independent apoptosis and p53-dependent block of DNA rereplication following mitotic spindle inhibition in human cells. , 1999, Experimental cell research.

[43]  P. Sorger,et al.  Retention of the BUB3 checkpoint protein on lagging chromosomes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[44]  D. Banerjee,et al.  Overexpression of p21(waf1) decreases G2-M arrest and apoptosis induced by paclitaxel in human sarcoma cells lacking both p53 and functional Rb protein. , 1999, Molecular pharmacology.

[45]  P Wadsworth,et al.  Taxol suppresses dynamics of individual microtubules in living human tumor cells. , 1999, Molecular biology of the cell.

[46]  E. Solary,et al.  Fas Ligand-independent, FADD-mediated Activation of the Fas Death Pathway by Anticancer Drugs* , 1999, The Journal of Biological Chemistry.

[47]  S. Leach,et al.  p21Waf1/Cip1 Inhibition of Cyclin E/Cdk2 Activity Prevents Endoreduplication after Mitotic Spindle Disruption , 1999, Molecular and Cellular Biology.

[48]  B. Pollock Obstacles and opportunities for the use of health‐related quality‐of‐life assessment in pediatric cancer clinical trials (discussion) , 1999, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[49]  G. Stark,et al.  Mechanisms of G 2 Arrest in Response to Overexpression of p 53 , 1999 .

[50]  D. Israeli,et al.  p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs , 1998, The Journal of experimental medicine.

[51]  Jun Yao,et al.  Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase. , 1998, Molecular cell.

[52]  S. Horwitz,et al.  Mechanisms of Taxol-induced cell death are concentration dependent. , 1998, Cancer research.

[53]  R. Himes,et al.  Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action , 1998 .

[54]  A Elhajouji,et al.  Spindle poisons can induce polyploidy by mitotic slippage and micronucleate mononucleates in the cytokinesis-block assay. , 1998, Mutagenesis.

[55]  S. Jee,et al.  Taxol-induced p34cdc2 kinase activation and apoptosis inhibited by 12-O-tetradecanoylphorbol-13-acetate in human breast MCF-7 carcinoma cells. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[56]  V. Baldin,et al.  Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line , 1997, Oncogene.

[57]  A. Hyman,et al.  Coupling cell division and cell death to microtubule dynamics. , 1997, Current opinion in cell biology.

[58]  M. Bornens,et al.  Pulse treatment of interphasic HeLa cells with nanomolar doses of docetaxel affects centrosome organization and leads to catastrophic exit of mitosis. , 1997, Journal of cell science.

[59]  P. Giannakakou,et al.  Activities of the Microtubule-stabilizing Agents Epothilones A and B with Purified Tubulin and in Cells Resistant to Paclitaxel (Taxol®)* , 1997, The Journal of Biological Chemistry.

[60]  G. Shah,et al.  Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. , 1997, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[61]  C. Prives,et al.  p53: puzzle and paradigm. , 1996, Genes & development.

[62]  G. Demers,et al.  Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis , 1996, Nature Medicine.

[63]  D. Burke,et al.  Checkpoint genes required to delay cell division in response to nocodazole respond to impaired kinetochore function in the yeast Saccharomyces cerevisiae , 1995, Molecular and cellular biology.

[64]  C. Norbury,et al.  Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM. , 1995, Trends in biochemical sciences.

[65]  E. Lazarides,et al.  Taxol-Induced Mitotic Block Triggers Rapid Onset of a p53-Independent Apoptotic Pathway , 1995, Molecular medicine.

[66]  E. Lazarides,et al.  Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. , 1995, Cancer research.

[67]  R. Margolis,et al.  Microtubule dependency of p34cdc2 inactivation and mitotic exit in mammalian cells , 1994, The Journal of cell biology.

[68]  P. Kiener,et al.  Activation of p34cdc2 coincident with taxol-induced apoptosis. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[69]  R. Schimke,et al.  Life, death and genomic change in perturbed cell cycles. , 1994, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[70]  M. Jordan,et al.  Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[71]  R. Schimke,et al.  Cell line-specific differences in the control of cell cycle progression in the absence of mitosis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[72]  P. Schiff,et al.  Taxol stabilizes microtubules in mouse fibroblast cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[73]  P. Schiff,et al.  Promotion of microtubule assembly in vitro by taxol , 1979, Nature.